-
Technical Use of Angiotensin I/II (1-5) in RAS Research Work
2026-07-31
Angiotensin I/II (1-5) (Asp-Arg-Val-Tyr-Ile) provides a defined peptide fragment for precise modeling of blood pressure regulation and aldosterone signaling within the renin-angiotensin system (RAS). Its solubility and biochemical specificity make it suitable for cardiovascular and renal research, but it should not be used for unrelated peptide signaling studies.
-
ATM Inhibition Promotes Macropinocytosis and Metabolic Adapt
2026-07-31
This study reveals that inhibition of ATM kinase induces macropinocytosis, enabling cancer cells to survive in nutrient-poor environments. The findings identify a metabolic vulnerability in ATM-deficient tumors and suggest new avenues for targeting cancer metabolism.
-
Fluo-4 AM Calcium Assay Kit: Powering Mechanotransduction Re
2026-07-30
The Fluo-4 AM Calcium Assay Kit delivers ultra-sensitive, no-wash intracellular calcium detection, streamlining live-cell workflows for mechanotransduction and GPCR screening. Its optimized protocol and robust signal-to-noise performance set a new standard for dynamic Ca2+ imaging in tissue engineering and cell signaling studies.
-
Lycopene Inhibits DON-Induced Gut Injury via ERK Pathway Mod
2026-07-30
This study demonstrates that lycopene protects intestinal epithelial cells from deoxynivalenol (DON)-induced barrier dysfunction and NLRP3 inflammasome activation by targeting the ERK pathway. These findings suggest lycopene's potential as a therapeutic agent for mitigating mycotoxin-induced intestinal injury, offering implications for food safety and animal health research.
-
Plant Cell Lysis Buffer for WB and IP: Enhanced Protein Extr
2026-07-29
Unlock high-yield, native-state protein extraction from plant tissues with Plant Cell Lysis Buffer for WB and IP. This specialized buffer from APExBIO streamlines Western blotting, immunoprecipitation, and co-IP workflows—preserving protein integrity for reproducible, high-impact research.
-
U 46619: Precision Platelet Aggregation Inducer for Vascular
2026-07-29
U 46619 (11,9 epoxymethano-prostaglandin H2) stands out as a gold-standard TP receptor agonist for dissecting platelet function, vascular tone, and cardiovascular signaling. Its predictable EC50 values and robust solubility profile make it ideal for reproducible, high-sensitivity assays. Discover workflow enhancements, troubleshooting strategies, and evidence-driven protocol parameters that sharpen your experimental edge.
-
Thrombin B Chain Fragment: Precision Modulator in Fibrin-Ang
2026-07-28
Discover how the trypsin-like serine protease thrombin, specifically APExBIO’s Coagulation Factor II (Thrombin) B Chain Fragment [Homo sapiens], enables precise dissection of fibrinogen to fibrin conversion and endothelial invasion in angiogenesis. This article uniquely integrates molecular mechanism, assay design, and next-generation applications in vascular research.
-
Troglitazone: PPARγ Agonist Workflows in Oncology and Diabet
2026-07-28
Troglitazone’s dual PPARγ/α agonist action uniquely empowers researchers to dissect both metabolic dysfunction and tumor microenvironment modulation. This article translates recent discoveries in SPP1-targeted TAM reprogramming into actionable protocols and troubleshooting tips for advanced metabolic and oncology studies.
-
Fiber Density Modulates Collagen Phenotypes in Annulus Fibro
2026-07-27
This paper demonstrates that fiber density in electrospun scaffolds can directionally guide annulus fibrosus cell (AFC) phenotypes and collagen matrix heterogeneity via distinct mechanotransduction pathways. The findings reveal new mechanobiological design principles for engineering scaffolds that better recapitulate the complex structure and function of native intervertebral disc tissue.
-
SB743921 (SKU B1590): Precision KSP Inhibition for Cancer Re
2026-07-27
This article delivers a scenario-driven, evidence-based guide to using SB743921 (SKU B1590) as a selective kinesin spindle protein inhibitor for cancer research. By addressing real laboratory challenges in cell viability assays, protocol optimization, and vendor selection, it demonstrates how SB743921 ensures reproducibility and data integrity for in vitro and xenograft models.
-
PYR-41, Inhibitor of Ubiquitin-Activating Enzyme E1: Workflo
2026-07-26
PYR-41, a selective inhibitor of Ubiquitin-Activating Enzyme E1, empowers researchers to dissect protein degradation, modulate NF-κB signaling, and model inflammatory responses with precision. This article delivers actionable protocols, troubleshooting tips, and practical insights for leveraging PYR-41 in advanced ubiquitin-proteasome system inhibition workflows.
-
Reprogramming Mature Hepatocytes for Liver Regeneration: Mec
2026-07-25
This study demonstrates that transplanted mature hepatocytes can be reprogrammed into alpha-fetoprotein-positive (Afp+) transitional cells that fuel liver regeneration after injury. By integrating lineage tracing, scRNA-seq, and scATAC-seq, the research uncovers distinct metabolic and signaling pathways that govern these reprogrammed cells’ proliferation and differentiation, clarifying mechanisms previously unknown in hepatic regenerative biology.
-
Protein A/G Magnetic Co-IP/IP Kit: Mechanism, Evidence & Use
2026-07-24
The Protein A/G Magnetic Co-IP/IP Kit leverages recombinant Protein A/G magnetic beads for efficient, specific immunoprecipitation of mammalian protein complexes. This kit enables reproducible protein-protein interaction analysis and antibody purification using magnetic beads. Its performance is validated in recent peer-reviewed studies examining neuronal injury models.
-
FLOT1–FOSL2–EphA2 Axis Drives Microglial Polarization in AD
2026-07-24
This study uncovers a mechanistic pathway by which the interaction between FLOT1 and FOSL2 upregulates EphA2 transcription, activating the p38/MAPK pathway and promoting pro-inflammatory microglial polarization in Alzheimer's disease models. These findings highlight a novel therapeutic target for modulating neuroinflammation and cognitive decline in AD.
-
ZK53: Human Mitochondrial Serine Protease ClpP Activator Wor
2026-07-23
ZK53 is a next-generation human mitochondrial serine protease ClpP activator that enables targeted disruption of mitochondrial proteostasis, with profound applications in cancer metabolism research and selective tumor cell eradication. Its exceptional selectivity, well-characterized activation parameters, and in vivo safety make it an indispensable tool for dissecting mitochondrial dysfunction, ferroptosis sensitization, and DNA damage pathways in translational oncology.